Here are relevant reports on : clinical-collaboration-software-market
-
Healthcare IoT Market by Usage (Embedded System, Wireless Network), Product (Monitoring & Notification System, Software), End User (Hospital, Academia, Government), Application (Telemedicine, Clinical Trial, Asset Management)- Global Forecasts to 2019
Emerging markets including Middle East, China, India, Mexico, and Brazil have become attractive destinations for companies engaged in the development and distribution of healthcare IoT products. A number of factors such as growing adoption of cloud-based and mobile healthcare technologies in emerging countries, rising medical tourism due to low cost healthcare facilities, and expansion of healthcare infrastructure across emerging countries (especially in rural areas) are offering high growth opportunities for players active in the global healthcare IoT market.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Antinuclear Antibody Test Market by Product (Reagents & Assay Kits, Systems, Software, Services), Technique (Immunofluorescence, Elisa, Multiplex), Disease (Rheumatoid Arthritis, SLE), End User (Clinical Labs, Hospitals) - Global Forecast to 2021
The global antinuclear antibody test market size is projected to grow at a CAGR of 12.4%. This market is segmented based on products, diseases, techniques, end users, and regions. On the basis of products, the ANA testing market is segmented into assay kits & reagents, systems, and software & services. The assay kits & reagents segment is expected to account for the largest share of the global ANA testing market, primarily due to the growing number of reagent rental agreements and increasing prevalence of autoimmune diseases worldwide.
- Published: September 2016
- Price: $ 4950
- TOC Available:
-
Nurse Training Software Market by Offering (LMS, Simulation, Microlearning, Adaptive Learning), Deployment (Cloud), Training (Basic, Clinical Procedure, Compliance, Regulatory, CNE), End User (Hospitals, Nursing School) & Region - Global Forecasts to 2030
The Nurse Training Software market, valued at USD 1.17 billion in 2024, stood at USD 1.35 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of USD 2.65 billion by the end of the period. The growth of the nurse training software market is driven by nursing workforce shortages, rising skill-gap pressures, and the need for scalable, standardized, and continuous clinical education to maintain quality of care.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
RNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028
The global RNA analysis market, valued at US$4.8 billion in 2022, stood at US$5.3 billion in 2023 and is projected to advance at a resilient CAGR of 13.4% from 2023 to 2028, culminating in a forecasted valuation of US$9.9 billion by the end of the period. Various elements such as increasing R&D activities, increasing government funding for drug discovery research, and growing pharmaceutical & biological industries are the major growth factors for this market.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Medical Terminology Software Market Size by Application (Data Aggregation, Reimbursement, Data Integration, Clinical Trials), Products & Services (Services, Platforms), End User (Healthcare Providers, Healthcare Payers, IT Vendors) & Region - Global Forecast to 2027
The size of global medical terminology software market in terms of revenue was estimated to be worth USD 1.0 billion in 2022 and is poised to reach USD 2.5 billion by 2027, growing at a CAGR of 19.3% from 2022 to 2027. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: July 2022
- Price: $ 4950
- TOC Available:
-
Asia Pacific Healthcare IT Market by Solution [Clinical (EHR, PACs & VNA, Telehealth, CDSS, Medical Image), Nonclinical (Clinical Analytics, RCM, Interoperability), Service (Claim, Billing)], End User [Hospital, ASC, Pharmacy, Payer]-Forecast to 2030
The Asia Pacific Healthcare IT market, valued at USD 68.96 billion in 2024, stood at USD 80.69 billion in 2025 and is projected to advance at a resilient CAGR of 17.6% from 2025 to 2030, culminating in a forecasted valuation of USD 181.30 billion by the end of the period. The Asia Pacific healthcare IT market is growing steadily, driven by increasing healthcare digitalization, rising patient volumes, government initiatives to adopt health IT, and expanding use of cloud, AI, and analytics in the region.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Coagulation Analyzer Market by Product (Clinical Laboratory Analyzers, Consumables, Reagents, Systems), Test (PT Test, APT Test, D-Dimer Test), Technology (Optical, Mechanical), End User (Hospitals, Clinical Laboratory) & Region - Global Forecast to 2030
Global coagulation analyzers market valued at $3516.0M in 2024, reached $3,770.9M in 2025, and is projected to grow at a robust 7.2% CAGR, hitting $5,335.9M by 2030. The market is experiencing steady growth, primarily driven by the increasing prevalence of blood clotting disorders such as hemophilia and deep vein thrombosis. As the global population ages and chronic illnesses become more common, the demand for quick and accurate diagnostic tools continues to rise.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) - Global Forecast to 2027
The global Endocrine Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the endocrine disorders such as thyroid imbalance, diabetes, Polycystic Ovary Syndrome, etc. Also, the increasing government funding and rising awareness for the endocrine hormone tests for the diagnosis and management of the endocrine disorder have also fueled the growth of the market.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Healthcare BPO Market by Life Science (Drug Discovery, Clinical Trial, Regulatory), Provider (RCM, Clinical Documentation, Patient Engagement), Payer (Billing, Claims), Technology (BPaaS, AI-enabled), Model (Onshore, Offshore) - Global Forecast to 2031
The global healthcare BPO market is projected to reach USD 735.05 billion by 2031, growing at a CAGR of 9.8% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
